Aileron Therapeutics Inc (ALRN)
3.85
+0.09
(+2.39%)
USD |
NASDAQ |
May 06, 11:52
Aileron Therapeutics Total Liabilities (Quarterly): 99.12M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 99.12M |
| September 30, 2023 | 1.624M |
| June 30, 2023 | 1.197M |
| March 31, 2023 | 2.884M |
| December 31, 2022 | 3.384M |
| September 30, 2022 | 4.536M |
| June 30, 2022 | 5.151M |
| March 31, 2022 | 4.146M |
| December 31, 2021 | 4.577M |
| September 30, 2021 | 4.659M |
| June 30, 2021 | 4.401M |
| March 31, 2021 | 3.252M |
| December 31, 2020 | 4.179M |
| September 30, 2020 | 9.781M |
| June 30, 2020 | 9.471M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.60M |
| December 31, 2019 | 10.42M |
| September 30, 2019 | 11.14M |
| June 30, 2019 | 10.21M |
| March 31, 2019 | 9.552M |
| December 31, 2018 | 10.71M |
| September 30, 2018 | 12.10M |
| June 30, 2018 | 9.709M |
| March 31, 2018 | 4.856M |
| December 31, 2017 | 4.891M |
| September 30, 2017 | 5.023M |
| June 30, 2017 | 135.88M |
| March 31, 2017 | 2.875M |
| December 31, 2016 | 133.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.197M
Minimum
Jun 2023
99.12M
Maximum
Dec 2023
10.78M
Average
4.577M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 88.86M |
| INVO Bioscience Inc | 20.00M |
| Bio-Path Holdings Inc | 2.779M |
| SINTX Technologies Inc | 6.593M |
| NovaBay Pharmaceuticals Inc | 5.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.01M |
| Shareholders Equity (Quarterly) | 6.887M |